2057575
Last Update Posted: 2019-06-04
Recruiting has ended
All Genders accepted | 18 Years + |
298 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
Study Assessing Safety and Efficacy of PG324 Ophthalmic Solution in Patients With Elevated Intraocular Pressure
To evaluate the ocular hypotensive efficacy of PG324 ophthalmic solution relative to its individual components in patients with open angle glaucoma or ocular hypertension.
Eligibility
Relevant conditions:
Open Angle Glaucoma
Ocular Hypertension
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov